Our group focuses on developing and advancing clinical neuroimaging. We are a multidisciplinary team of physicists, physiologists, radiologists, and specialist clinicians who focus on methods to measure perfusion (ASL/DSC/DCE), diffusion (DTI), and metabolism (hyperpolarised 13C) in pathologies such as neuroinflamamtory pathologies (such as Multiple Sclerosis) and paediatric neurooncology.
Our work is heavily clinically based and we are excited to work with collaborators to advance and refine the role of neuroimaging in the patient care pathway.
Collaborators
- Alex Green (Nuffield Department of Clinical Neurosciences, Oxford)
- Gabriele De Luca (Nuffield Department of Clinical Neurosciences, Oxford)
- Silvia Messina (Medical Sciences Division, Oxford)
- Fergus Gleeson (Department of Oncology, Oxford)
- Bartek Papiez (Big Data Institute, Oxford)
- Oliver Rider
- Damian Tyler
- Andrew Lewis
- Ladislav Valkovic
- Damian Jenkins (Nuffield Department of Clinical Neurosciences, Oxford)
- Shaun Wilson (Oxford University Hospitals NHS Foundation Trust)
- Esther Hammond (Department of Oncology, Oxford)
- Monica Olcina (Department of Oncology, Oxford)
- Tim Lawrence (Nuffield Department of Clinical Neurosciences, Oxford)
- Olaf Ansorge (Nuffield Department of Clinical Neurosciences, Oxford)
- Marco Pisa (Nuffield Department of Clinical Neurosciences, Oxford)
- Ferdia Gallagher (Cambridge University Hospitals NHS Foundation Trust)
- Dorothee Auer (University of Nottingham)
- Sebastien Serres (University of Nottingham)
- Claudia Testa (University of Bologna, Italy)
- Anders Wahlin (Umea University, Sweden)
- John Apps (University of Birmingham)
- Christopher Laustsen (Aarhus University, Denmark)
- Frank Riemer (Decode-PD)
FUNDERS
- Medical Research Council
- Bristol Myers Squibb
- GE Healthcare
- John Fell Fund
- Oxford University Hospitals Charities
